{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:53:21Z","timestamp":1784307201448,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"DOI":"10.1186\/s13756-024-01498-y","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T01:24:36Z","timestamp":1733102676000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis"],"prefix":"10.1186","volume":"13","author":[{"given":"Seongman","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungkeun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inah","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Oh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"1498_CR1","doi-asserted-by":"crossref","unstructured":"Johnson S, Lavergne V, Skinner AM, Society for Healthcare Epidemiology of America (SHEA). 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and: 2021; 73(5): e1029-e44.","DOI":"10.1093\/cid\/ciab549"},{"issue":"Suppl 2","key":"1498_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","volume":"27","author":"J van Prehn","year":"2021","unstructured":"van Prehn J, Reigadas E, Vogelzang EH, et al. European Society of Clinical Microbiology and Infectious diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2021;27(Suppl 2):S1\u201321.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"},{"issue":"4","key":"1498_CR3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/infdis\/172.4.993","volume":"172","author":"DK Shay","year":"1995","unstructured":"Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of Vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 1995;172(4):993\u20131000.","journal-title":"J Infect Dis"},{"key":"1498_CR4","doi-asserted-by":"crossref","unstructured":"Gerding DN. Is there a relationship between Vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 1997; 25 Suppl 2: S206\u201310.","DOI":"10.1086\/516247"},{"issue":"3","key":"1498_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7326\/0003-4819-135-3-200108070-00009","volume":"135","author":"SK Fridkin","year":"2001","unstructured":"Fridkin SK, Edwards JR, Courval JM, et al. The effect of Vancomycin and third-generation cephalosporins on prevalence of Vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med. 2001;135(3):175\u201383.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1498_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13756-023-01332-x","volume":"12","author":"M Meschiari","year":"2023","unstructured":"Meschiari M, Kaleci S, Monte MD, et al. Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study. Antimicrob Resist Infect Control. 2023;12(1):126.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1498_CR7","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.2217\/fmb-2019-0157","volume":"14","author":"S Zilberman-Itskovich","year":"2019","unstructured":"Zilberman-Itskovich S, Youngster I, Lazarovitch T, et al. Potential impact of removing metronidazole from treatment armamentarium of mild acute Clostridioides difficile infection. Future Microbiol. 2019;14:1489\u201395.","journal-title":"Future Microbiol"},{"issue":"3","key":"1498_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/cid\/ciz871","volume":"71","author":"VW Stevens","year":"2020","unstructured":"Stevens VW, Khader K, Echevarria K, et al. Use of oral vancomycin for Clostridioides difficile infection and the risk of vancomycin-resistant Enterococci. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2020;71(3):645\u201351.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"8","key":"1498_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1469-0691.2008.02026.x","volume":"14","author":"EI Kritsotakis","year":"2008","unstructured":"Kritsotakis EI, Christidou A, Roumbelaki M, Tselentis Y, Gikas A. The dynamic relationship between antibiotic use and the incidence of Vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2008;14(8):747\u201354.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"},{"key":"1498_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13756-017-0253-5","volume":"6","author":"C Remschmidt","year":"2017","unstructured":"Remschmidt C, Behnke M, Kola A, et al. The effect of antibiotic use on prevalence of nosocomial Vancomycin-resistant enterococci- an ecologic study. Antimicrob Resist Infect Control. 2017;6:95.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"1498_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13756-023-01302-3","volume":"12","author":"P Laffont-Lozes","year":"2023","unstructured":"Laffont-Lozes P, Larcher R, Salipante F, et al. Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review. Antimicrob Resist Infect Control. 2023;12(1):100.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"10","key":"1498_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200003093421007","volume":"342","author":"BE Murray","year":"2000","unstructured":"Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000;342(10):710\u201321.","journal-title":"N Engl J Med"},{"issue":"5","key":"1498_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1086\/527394","volume":"46","author":"M Drees","year":"2008","unstructured":"Drees M, Snydman DR, Schmid CH, et al. Prior environmental contamination increases the risk of acquisition of Vancomycin-resistant enterococci. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2008;46(5):678\u201385.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"3","key":"1498_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jhin.2019.01.008","volume":"102","author":"P Zachariah","year":"2019","unstructured":"Zachariah P, Freedberg DE. Vancomycin use in surrounding patients during critical illness and risk for persistent colonization with Vancomycin-resistant Enterococcus. J Hosp Infect. 2019;102(3):343\u20136.","journal-title":"J Hosp Infect"},{"issue":"1","key":"1498_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhin.2018.07.018","volume":"101","author":"MJ Zhou","year":"2019","unstructured":"Zhou MJ, Li J, Salmasian H, Zachariah P, Yang YX, Freedberg DE. The local hospital milieu and healthcare-associated Vancomycin-resistant enterococcus acquisition. J Hosp Infect. 2019;101(1):69\u201375.","journal-title":"J Hosp Infect"},{"issue":"4","key":"1498_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2165\/00003088-198611040-00001","volume":"11","author":"GR Matzke","year":"1986","unstructured":"Matzke GR, Zhanel GG, Guay DR. Clinical pharmacokinetics of Vancomycin. Clin Pharmacokinet. 1986;11(4):257\u201382.","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 1","key":"1498_CR17","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1086\/491712","volume":"42","author":"MJ Rybak","year":"2006","unstructured":"Rybak MJ. The pharmacokinetic and pharmacodynamic properties of Vancomycin. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2006;42(Suppl 1):S35\u20139.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"1","key":"1498_CR18","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41598-020-57776-3","volume":"10","author":"V Dinu","year":"2020","unstructured":"Dinu V, Lu Y, Weston N, et al. The antibiotic Vancomycin induces complexation and aggregation of gastrointestinal and submaxillary mucins. Sci Rep. 2020;10(1):960.","journal-title":"Sci Rep"},{"issue":"10","key":"1498_CR19","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/infdis\/jiv256","volume":"212","author":"BB Lewis","year":"2015","unstructured":"Lewis BB, Buffie CG, Carter RA, et al. Loss of microbiota-mediated colonization resistance to Clostridium difficile infection with oral vancomycin compared with metronidazole. J Infect Dis. 2015;212(10):1656\u201365.","journal-title":"J Infect Dis"},{"issue":"2","key":"1498_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF00379817","volume":"81","author":"YT Prairie","year":"1989","unstructured":"Prairie YT, Bird DF. Some misconceptions about the spurious correlation problem in the ecological literature. Oecologia. 1989;81(2):285\u20138.","journal-title":"Oecologia"},{"issue":"2","key":"1498_CR21","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1152\/japplphysiol.00031.2004","volume":"97","author":"G Atkinson","year":"2004","unstructured":"Atkinson G, Watson P, Maughan RJ, Shirreffs SM, Nevill AM. A spurious correlation. J Appl Physiol (1985). 2004;97(2):792\u20133. author reply 3.","journal-title":"J Appl Physiol (1985)"}],"container-title":["Antimicrobial Resistance & Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-024-01498-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-024-01498-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-024-01498-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T14:10:21Z","timestamp":1733148621000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-024-01498-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1186\/s13756-024-01498-y","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}